Not yet recruiting
Parkinson's disease+1
Not yet recruitingStudy of serotonin system changes in early Parkinson's disease using [11C]DASB and [11C]SB207145 PET imaging in people with SNCA gene mutations
InvestigationalNo placebo
Study of serotonin system changes in early Parkinson's disease using [11C]DASB and [11C]SB207145 PET imaging in people with SNCA gene mutations
InvestigationalNo placebo
- Disease:Parkinson's diseaseDisease prodromal stage
- Substances:(1-(11C)METHYLPIPERIDIN-4-YL)METHYL 5-AMINO-6-CHLORO-1,4-BENZODIOXINE-8-CARBOXYLATE3-AMINO-4-[2-[[METHYL((111C)METHYL)AMINO]METHYL]PHENYL]SULFANYLBENZONITRILE
Countries:
France
France- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:(1-(11C)METHYLPIPERIDIN-4-YL)METHYL 5-AMINO-6-CHLORO-1,4-BENZODIOXINE-8-CARBOXYLATE
- Sponsor:Inserm